Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$0.73 - $2.73 $4,317 - $16,147
-5,915 Reduced 38.92%
9,284 $21,000
Q4 2023

Feb 13, 2024

SELL
$0.38 - $0.91 $1,847 - $4,424
-4,862 Reduced 24.24%
15,199 $13,000
Q3 2023

Nov 14, 2023

SELL
$0.79 - $2.83 $70,241 - $251,623
-88,913 Reduced 81.59%
20,061 $17,000
Q2 2023

Aug 21, 2023

SELL
$2.49 - $20.59 $4,925 - $40,727
-1,978 Reduced 1.78%
108,974 $294,000
Q1 2023

May 09, 2023

SELL
$15.95 - $25.18 $23,414 - $36,964
-1,468 Reduced 1.31%
110,952 $2.07 Million
Q4 2022

Feb 14, 2023

BUY
$13.27 - $17.73 $21,484 - $28,704
1,619 Added 1.46%
112,420 $1.8 Million
Q3 2022

Nov 18, 2022

SELL
$11.4 - $14.6 $20,782 - $26,615
-1,823 Reduced 1.62%
110,801 $1.44 Million
Q2 2022

Aug 15, 2022

BUY
$7.94 - $12.96 $36,428 - $59,460
4,588 Added 4.25%
112,624 $1.19 Million
Q1 2022

May 16, 2022

SELL
$12.02 - $16.79 $106,581 - $148,876
-8,867 Reduced 7.58%
108,036 $1.3 Million
Q4 2021

Feb 15, 2022

BUY
$9.93 - $15.39 $20,336 - $31,518
2,048 Added 1.78%
116,903 $1.65 Million
Q3 2021

Nov 15, 2021

SELL
$10.18 - $26.64 $38,836 - $101,631
-3,815 Reduced 3.21%
114,855 $1.17 Million
Q2 2021

Aug 16, 2021

SELL
$18.57 - $35.68 $155,393 - $298,570
-8,368 Reduced 6.59%
118,670 $3.16 Million
Q1 2021

May 18, 2021

SELL
$31.0 - $55.72 $15,283 - $27,469
-493 Reduced 0.39%
127,038 $4.41 Million
Q4 2020

Feb 16, 2021

BUY
$37.09 - $48.97 $1,261 - $1,664
34 Added 0.03%
127,531 $4.73 Million
Q3 2020

Nov 17, 2020

BUY
$40.47 - $45.5 $90,329 - $101,556
2,232 Added 1.78%
127,497 $5.24 Million
Q2 2020

Aug 17, 2020

BUY
$32.57 - $42.83 $191,120 - $251,326
5,868 Added 4.91%
125,265 $5.08 Million
Q1 2020

May 13, 2020

SELL
$23.3 - $45.96 $13,770 - $27,162
-591 Reduced 0.49%
119,397 $4.15 Million
Q4 2019

Feb 14, 2020

SELL
$34.58 - $48.06 $33,922 - $47,146
-981 Reduced 0.81%
119,988 $5.15 Million
Q3 2019

Nov 15, 2019

BUY
$36.98 - $48.45 $53,436 - $70,010
1,445 Added 1.21%
120,969 $4.47 Million
Q2 2019

Aug 14, 2019

BUY
$35.13 - $55.53 $107,743 - $170,310
3,067 Added 2.63%
119,524 $5.4 Million
Q1 2019

May 09, 2019

SELL
$42.83 - $59.91 $110,929 - $155,166
-2,590 Reduced 2.18%
116,457 $6.33 Million
Q4 2018

Feb 13, 2019

BUY
$37.97 - $60.16 $177,547 - $281,308
4,676 Added 4.09%
119,047 $5.51 Million
Q3 2018

Nov 14, 2018

SELL
$56.3 - $67.25 $2,252 - $2,690
-40 Reduced 0.03%
114,371 $6.95 Million
Q2 2018

Aug 14, 2018

BUY
$44.9 - $64.95 $371,098 - $536,811
8,265 Added 7.79%
114,411 $7.16 Million
Q1 2018

May 15, 2018

SELL
$45.35 - $61.65 $168,747 - $229,399
-3,721 Reduced 3.39%
106,146 $4.9 Million
Q4 2017

Feb 14, 2018

BUY
$41.95 - $60.1 $160,290 - $229,642
3,821 Added 3.6%
109,867 $5.21 Million
Q3 2017

Nov 13, 2017

BUY
$33.4 - $53.9 $3.54 Million - $5.72 Million
106,046
106,046 $5.71 Million

Others Institutions Holding FGEN

About FIBROGEN INC


  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $31.9M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.